%0 Journal Article
%T In Situ immunization by bispecific antibody targeted T cell therapy in breast cancer
%A Archana Thakur
%A Lawrence G. Lum
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2015.1055061
%X Metastatic breast cancer remains an incurable disease. Most patients experience objective treatment responses associated with palliation of symptoms; however, progression inevitably occurs. Thus, there is an urgent need for innovative therapeutic strategies that may halt disease progression. Adoptive T-cell therapy is a potent and promising treatment option with the potential to harness the intrinsic antitumor power of the immune system and provide long-term immunity against cancer
%K adaptive T cell therapy
%K breast cancer
%K bispecific antibody
%K immunotherapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839366/